eptifibatide

基本解釋

There is no apparent difference in early outcomes of patients treated with eptifibatide compared with patients treated with abciximab.
接受替非羅班治療的患者的早期結(jié)果和接受阿昔單抗治療的患者相比，不存在顯著性差異。
Keywords acute coronary syndrome;myocardial infarction;platelet aggregation;eptifibatide;
急性冠脈綜合征;心肌梗死;血小板聚集;依替巴肽;
Early initiation of eptifibatide in the emergency department before primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Results of the Time to Integrilin Therapy in Acute Myocardial Infarction(TITAN)-TIMI 34 trial
ST段抬高型心肌梗死患者行直接經(jīng)皮冠狀動(dòng)脈介入術(shù)前依替巴肽的急診早期使用:TITAN(急性心肌梗死患者中至應(yīng)用依替巴肽治療時(shí)間)-TIMI34試驗(yàn)的結(jié)果